September 14, 2018

Innovator Liability for Drug Manufacturers

Tarifa Laddon, Patrick Reilly and Joshua Busch authored an article in For the Defense explaining the theory known as "innovator liability" and how it is affecting name-brand manufacturers. 
"Under an innovator liability theory, plaintiffs attempt to shift blame from the generic manufacturer of a drug that allegedly harmed a plaintiff to the name-brand manufacturer of an equivalent product not ingested by the plaintiff."
The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.